14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Calithera Biosciences Stock Forecast

NASDAQ:CALA BUY SELL

$0.22 (-4.27%)

Volume: 1.6M

Closed: May 23, 2022

Hollow Logo Score: -4.930

Calithera Biosciences Stock Forecast

BUY SELL NASDAQ:CALA
$0.22 (-4.27%)

Volume: 1.6M

Closed: May 23, 2022

Score Hollow Logo -4.930

Calithera Biosciences Stock Forecast NASDAQ:CALA

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-11 809.09% Wells Fargo $3.00 $2.00 Maintains Equal-Weight
2022-04-04 809.09% SVB Leerink $3.00 $2.00 Maintains Outperform
2022-01-31 1718.18% Ladenburg Thalmann $4.00 Initiates Coverage On Buy
2022-01-20 1263.64% SVB Leerink $1.00 $3.00 Upgrades Market Perform Outperform
2021-11-08 - HC Wainwright & Co. - Downgrades Buy Neutral
2021-11-05 - William Blair - Downgrades Outperform Market Perform
2021-01-05 1718.18% HC Wainwright & Co. $9.50 $4.00 Maintains Buy
2021-01-05 809.09% SVB Leerink $7.00 $2.00 Downgrades Outperform Market Perform
2020-08-11 3081.82% SVB Leerink $9.00 $7.00 Maintains Outperform
2020-05-08 4218.18% HC Wainwright & Co. $7.00 $9.50 Reiterates Buy
2020-03-27 3081.82% Citigroup $8.00 $7.00 Maintains Buy
2020-03-27 2627.27% Jefferies $6.00 Initiates Coverage On Buy
2019-11-19 3081.82% HC Wainwright & Co. $7.00 Initiates Coverage On Buy
2019-05-30 4445.45% Citigroup $10.00 Assumes Buy

CALA Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -47.62% during the next 3 months and, with a 90% probability hold a price between $0.0589 and $0.21 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-25 $0.11 $0.25 $0.39
2022-05-26 $0.10 $0.24 $0.39
2022-05-27 $0.0947 $0.24 $0.38
2022-05-31 $0.0887 $0.23 $0.37
2022-06-01 $0.0828 $0.23 $0.37
2022-06-02 $0.0769 $0.22 $0.36
2022-06-03 $0.0709 $0.21 $0.36
2022-06-06 $0.0650 $0.21 $0.35
2022-06-07 $0.0591 $0.20 $0.34
2022-06-08 $0.0531 $0.20 $0.34
2022-06-09 $0.0472 $0.19 $0.33
2022-06-10 $0.0412 $0.18 $0.33
2022-06-13 $0.0353 $0.18 $0.32
2022-06-14 $0.0294 $0.17 $0.32
2022-06-15 $0.0234 $0.17 $0.31
2022-06-16 $0.0175 $0.16 $0.30
2022-06-17 $0.0116 $0.15 $0.30
2022-06-21 $0.0056 $0.15 $0.29
2022-06-22 $-0.0003 $0.14 $0.29
2022-06-23 $-0.0063 $0.14 $0.28
2022-06-24 $-0.0122 $0.13 $0.27
2022-06-27 $-0.0181 $0.12 $0.27
2022-06-28 $-0.0241 $0.12 $0.26
2022-06-29 $-0.0300 $0.11 $0.26
2022-06-30 $-0.0359 $0.11 $0.25
2022-07-01 $-0.0419 $0.10 $0.24
2022-07-05 $-0.0478 $0.0951 $0.24
2022-07-06 $-0.0538 $0.0892 $0.23
2022-07-07 $-0.0597 $0.0833 $0.23
2022-07-08 $-0.0656 $0.0773 $0.22

About Calithera Biosciences

Calithera Biosciences Calithera Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Its lead product candidate includes CB-839, an inhibitor of glutaminase, which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myelom... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT